AngioDynamics/$ANGO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AngioDynamics
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Geographically operates in the USA and Other countries, maximum revenue from the USA.
Ticker
$ANGO
Sector
Primary listing
Employees
632
Headquarters
Website
AngioDynamics Metrics
BasicAdvanced
$605m
-
-$0.88
0.34
-
Price and volume
Market cap
$605m
Beta
0.34
52-week high
$15.20
52-week low
$8.36
Average daily volume
525k
Financial strength
Current ratio
2.187
Quick ratio
1.37
Long term debt to equity
5.421
Total debt to equity
6.414
Interest coverage (TTM)
-77.48%
Profitability
EBITDA (TTM)
-0.212
Gross margin (TTM)
54.62%
Net profit margin (TTM)
-11.48%
Operating margin (TTM)
-7.02%
Effective tax rate (TTM)
-1.22%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
-5.13%
Return on equity (TTM)
-20.77%
Valuation
Price to revenue (TTM)
1.897
Price to book
3.57
Price to tangible book (TTM)
5.89
Price to free cash flow (TTM)
1,195.945
Free cash flow yield (TTM)
0.08%
Free cash flow per share (TTM)
0.012
Growth
Revenue change (TTM)
9.46%
Earnings per share change (TTM)
6.34%
3-year revenue growth (CAGR)
-1.86%
10-year revenue growth (CAGR)
-0.93%
3-year earnings per share growth (CAGR)
-12.70%
10-year earnings per share growth (CAGR)
-3.08%
What the Analysts think about AngioDynamics
Analyst ratings (Buy, Hold, Sell) for AngioDynamics stock.
AngioDynamics Financial Performance
Revenues and expenses
AngioDynamics Earnings Performance
Company profitability
AngioDynamics News
AllArticlesVideos
AngioDynamics to Participate in Upcoming Investor Conferences
Business Wire·2 days ago
AngioDynamics Q4 Earnings Call Highlights
MarketBeat·2 weeks ago
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.